These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1544 related items for PubMed ID: 33211254

  • 1. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC, Lee HF, Chao TF, Li PR, Liu JR, Wu LS, Chang SH, Yeh YH, Kuo CT, Chan YH, Lip GYH.
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [Abstract] [Full Text] [Related]

  • 2. Real-world Comparisons of Direct Oral Anticoagulants for Stroke Prevention in Asian Patients with Non-valvular Atrial Fibrillation: a Systematic Review and Meta-analysis.
    Chan YH, Lee HF, Chao TF, Wu CT, Chang SH, Yeh YH, See LC, Kuo CT, Chu PH, Wang CL, Lip GYH.
    Cardiovasc Drugs Ther; 2019 Dec; 33(6):701-710. PubMed ID: 31745687
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
    Chen HY, Ou SH, Huang CW, Lee PT, Chou KJ, Lin PC, Su YC.
    Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Real-World Comparative Effectiveness, Safety, and Health Care Costs of Oral Anticoagulants in Nonvalvular Atrial Fibrillation Patients in the U.S. Department of Defense Population.
    Gupta K, Trocio J, Keshishian A, Zhang Q, Dina O, Mardekian J, Rosenblatt L, Liu X, Hede S, Nadkarni A, Shank T.
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1116-1127. PubMed ID: 30212268
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Direct Comparison of the Effectiveness and Safety Among Direct Oral Anticoagulants and Warfarin in Japanese Patients: Nationwide Cohort Study in Japan.
    Katayama S, Aoki Y, Akita A, Satake R, Tohkin M.
    Clin Pharmacol Ther; 2024 Oct; 116(4):1023-1033. PubMed ID: 38818726
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Severe Kidney Disease or Undergoing Hemodialysis.
    Coleman CI, Kreutz R, Sood NA, Bunz TJ, Eriksson D, Meinecke AK, Baker WL.
    Am J Med; 2019 Sep; 132(9):1078-1083. PubMed ID: 31054829
    [Abstract] [Full Text] [Related]

  • 12. Direct oral anticoagulants for oral anticoagulants-naïve Asian patients with atrial fibrillation and end-stage renal disease undergoing dialysis.
    Roh JH, Kim YG, Kim D, Park S, Park KS, Kim M, Hwang KW, Hwang W, Park GM, Lee JH.
    Sci Rep; 2024 Jun 25; 14(1):14679. PubMed ID: 38918543
    [Abstract] [Full Text] [Related]

  • 13. Direct Oral Anticoagulants Versus Warfarin Across the Spectrum of Kidney Function: Patient-Level Network Meta-Analyses From COMBINE AF.
    Harrington J, Carnicelli AP, Hua K, Wallentin L, Patel MR, Hohnloser SH, Giugliano RP, Fox KAA, Hijazi Z, Lopes RD, Pokorney SD, Hong H, Granger CB.
    Circulation; 2023 Jun 06; 147(23):1748-1757. PubMed ID: 37042255
    [Abstract] [Full Text] [Related]

  • 14. Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation.
    Chan YH, Lee HF, See LC, Tu HT, Chao TF, Yeh YH, Wu LS, Kuo CT, Chang SH, Lip GYH.
    Chest; 2019 Sep 06; 156(3):529-543. PubMed ID: 31103697
    [Abstract] [Full Text] [Related]

  • 15. Effectiveness and Safety of Direct Oral Anticoagulants Versus Warfarin in Patients With Valvular Atrial Fibrillation : A Population-Based Cohort Study.
    Dawwas GK, Dietrich E, Cuker A, Barnes GD, Leonard CE, Lewis JD.
    Ann Intern Med; 2021 Jul 06; 174(7):910-919. PubMed ID: 33780291
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effectiveness and safety of low-dose rivaroxaban in Asians with non-valvular atrial fibrillation.
    Lee HF, Chan YH, Tu HT, Kuo CT, Yeh YH, Chang SH, Wu LS, See LC.
    Int J Cardiol; 2018 Jun 15; 261():78-83. PubMed ID: 29559181
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation: A retrospective cohort study.
    Holbrook A, Morrow R, Lee AYY, Foster G, Pullenyegum E.
    J Popul Ther Clin Pharmacol; 2020 Apr 13; 27(2):e28-e44. PubMed ID: 32320170
    [Abstract] [Full Text] [Related]

  • 20. Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis.
    Kuno T, Takagi H, Ando T, Sugiyama T, Miyashita S, Valentin N, Shimada YJ, Kodaira M, Numasawa Y, Briasoulis A, Burger A, Bangalore S.
    J Am Coll Cardiol; 2020 Jan 28; 75(3):273-285. PubMed ID: 31976865
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 78.